0000000000260973

AUTHOR

Jose María Díaz-fernández

showing 2 related works from this author

Retinoids and proliferative verrucous leukoplakia (PVL). A preliminary study.

2010

Objective. A study is made of the efficacy and adverse effects of retinoid therapy applied to the white lesions of proliferative verrucous leukoplakia (PVL). Material and methods. The results of retinoid therapy were evaluated in 17 patients diagnosed with PVL. Topical retinoids were used in 5 patients, in the form of two daily applications of 0.1% 13-cis-retinoic acid in orabase for an average of 6.17+/-3.13 months. Systemic retinoids were used in 11 patients, with the administration of 25 mg/day of acitretin in tablet form for an average of 5.41+/-2.02 months. One patient successively received the topical and systemic retinoid formulations. The course and results were evaluated on a blind…

AdultMalemedicine.medical_specialtymedicine.drug_classSystemic therapyAcitretinDesquamationLesionRetinoidsOral and maxillofacial pathologymedicineHumansRetinoidAdverse effectGeneral DentistryLeukoplakiaAgedAged 80 and overbusiness.industryMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]DermatologyOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryFemalemedicine.symptomLeukoplakia Oralbusinessmedicine.drugMedicina oral, patologia oral y cirugia bucal
researchProduct

Interleukin‐6 concentration changes in plasma and saliva in bisphosphonate‐related osteonecrosis of the jaws

2013

To determine the plasma and saliva levels of IL-6 in patients with bisphosphonate-related osteonecrosis of the jaws (BRONJ) and to investigate whether there is a correlation between more advanced stages of BRONJ and levels of IL-6.We studied three groups: group 1 consisted of 30 patients with BRONJ due to intravenous bisphosphonates (ivBP), group 2 consisted of 25 patients treated with ivBP but without BRONJ, and group 3 consisted of 15 healthy controls. In each case, we assayed plasma and saliva IL-6 samples using an ELISA test.Significantly, higher IL-6 values were found in both saliva and plasma in group 1 vs groups 2 and 3 (P  0.01). Group 1 showed no differences in plasma or saliva IL-…

Malemedicine.medical_specialtySalivamedicine.medical_treatmentDentistryGastroenterologyInternal medicinemedicineHumansIn patientStage (cooking)SalivaInterleukin 6General DentistryAgedDiphosphonatesbiologyInterleukin-6business.industryAdvanced stageBisphosphonateOtorhinolaryngologyElisa testbiology.proteinEtiologyBisphosphonate-Associated Osteonecrosis of the JawFemalebusinessOral Diseases
researchProduct